MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with I

Indoramin

Indoramin 20mg tablets

Use with caution

Stability notes for Indoramin 20mg tablets

Protect from light.

Provenance

This compatibility recommendation is derived from Doralese Tiltab 20mg tablets (Chemidex Pharma Ltd) and Indoramin 20mg tablets (Brown & Burk UK Ltd).

Suppliers (7) of Indoramin 20mg tablets
Indoramin 20mg tablets (A A H Pharmaceuticals Ltd)
Indoramin 20mg tablets (Alliance Healthcare (Distribution) Ltd)
Indoramin 20mg tablets (Brown & Burk UK Ltd)
Indoramin 20mg tablets (Essential Generics Ltd)
Indoramin 20mg tablets (Medihealth (Northern) Ltd)
Indoramin 20mg tablets (Phoenix Healthcare Distribution Ltd)
Indoramin 20mg tablets (Sigma Pharmaceuticals Plc)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.